<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>http://hboevidence.wikis.unsw.edu.au/index.php?action=history&amp;feed=atom&amp;title=Abidia</id>
	<title>Abidia - Revision history</title>
	<link rel="self" type="application/atom+xml" href="http://hboevidence.wikis.unsw.edu.au/index.php?action=history&amp;feed=atom&amp;title=Abidia"/>
	<link rel="alternate" type="text/html" href="http://hboevidence.wikis.unsw.edu.au/index.php?title=Abidia&amp;action=history"/>
	<updated>2026-10-06T08:16:38Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.31.0</generator>
	<entry>
		<id>http://hboevidence.wikis.unsw.edu.au/index.php?title=Abidia&amp;diff=3&amp;oldid=prev</id>
		<title>Gordoben: Imported from Wikispaces</title>
		<link rel="alternate" type="text/html" href="http://hboevidence.wikis.unsw.edu.au/index.php?title=Abidia&amp;diff=3&amp;oldid=prev"/>
		<updated>2018-01-20T23:20:49Z</updated>

		<summary type="html">&lt;p&gt;Imported from Wikispaces&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;lt;span style=&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 130%;&amp;quot;&amp;gt;'''Improved healing of ulcers, but no significant decrease in amputation rate in diabetic patients with lower limb chronic wounds.''' &amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
**&amp;lt;span style=&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 120%;&amp;quot;&amp;gt;Clinical Bottom Line: &amp;lt;/span&amp;gt;'''&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 120%;&amp;quot;&amp;gt;1. More ulcers healed at six weeks and one year with the addition of hyperbaric oxygen therapy. &amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 120%;&amp;quot;&amp;gt;2. No difference in major amputation rate. &amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 120%;&amp;quot;&amp;gt;'''Three-part Clinical Question:''' For diabetic patients with ischaemic lower-extremity ulcers, does the addition of hyperbaric oxygen, compared to other measures alone, result in improved healing or reduced amputation rates? &amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 120%;&amp;quot;&amp;gt;'''Search Terms:''' Diabetic ulcers, amputation &amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 120%;&amp;quot;&amp;gt;'''Appraised by:''' Michael Bennett, Dept. of Diving and Hyperbaric Medicine, Prince of Wales Hospital, Sydney, 7th July 2003 Email: [[mailto:m.bennett@unsw.edu.au | m.bennett@unsw.edu.au]] &amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 120%;&amp;quot;&amp;gt;'''The Study:''' Double-blinded randomised controlled trial with intention-to-treat. &amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 120%;&amp;quot;&amp;gt;'''The Study Patients:''' Diabetic patients with non-healing lower limb ulcers for at least 6 weeks of medical management and no vascular reconstruction planned. &amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 120%;&amp;quot;&amp;gt;'''Control group''' (N = 9; 8 analysed): Sham hyperbaric treatment with air breathing at 2.4ATA for ninety minutes daily to a total of 30 treatments. Intensive multidisciplinary wound management. &amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 120%;&amp;quot;&amp;gt;'''Experimental group''' (N = 9; 8 analysed): Regimen as above with 100% oxygen at 2.4ATA. Same wound management. &amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
**&amp;lt;span style=&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 120%;&amp;quot;&amp;gt;The Evidence: &amp;lt;/span&amp;gt;'''&lt;br /&gt;
&lt;br /&gt;
{| &lt;br /&gt;
| &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;'''Outcome''' &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;'''Time to outcome''' &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;'''Sham rate''' &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;'''HBO rate''' &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;'''Relative risk reduction''' &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;'''Absolute risk reduction''' &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;'''NNT''' &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
| &amp;lt;span style'''&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 110%;&amp;quot;&amp;gt;'''Failure to heal''' &amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;6 weeks &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;0.78 &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;0.33 &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;57% &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;0.45 &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;2 &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
| &amp;lt;span style'''&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 110%;&amp;quot;&amp;gt;'''95% CI:''' &amp;lt;/span&amp;gt; ||   ||   ||   || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;4% - 100% &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;0.03 to 0.86 &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;1 to 29 &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
| &amp;lt;span style'''&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 110%;&amp;quot;&amp;gt;'''Failure to heal''' &amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;1 year &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;0.89 &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;0.33 &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;63% &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;0.56 &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;2 &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
| &amp;lt;span style'''&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 110%;&amp;quot;&amp;gt;'''95% CI:''' &amp;lt;/span&amp;gt; ||   ||   ||   || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;21% - 100% &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;0.19 to 0.93 &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;1 to 5 &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
{| &lt;br /&gt;
| &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;'''Non-Event Outcomes''' &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;'''Time to outcome''' &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;'''Control group''' &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;'''Experimental group''' &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;'''Difference''' &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
| &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;Median wound area reduction (%) &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;Number of visits (sd) &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;Average cost (UKP) &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;1 year &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;1 year &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;1 year &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;52 &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;136.5 (126) &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;7,946 &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;100 &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;33.8 (62) &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;4, 972 &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;P'''0.027 &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;95%CI –3 to 209 &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;display: block; font-family: arial,helvetica,sans-serif; font-size: 110%; text-align: center;&amp;quot;&amp;gt;2,960 &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
**&amp;lt;span style=&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 120%;&amp;quot;&amp;gt;Comments: &amp;lt;/span&amp;gt;'''&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 120%;&amp;quot;&amp;gt;1. Small study with low power to detect a significant reduction in major amputation rate. One major amputation in each group. &amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 120%;&amp;quot;&amp;gt;2. No significant overall difference in SF36 between groups. &amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 120%;&amp;quot;&amp;gt;3. Two abstracts were clearly superseded by the full report. &amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 120%;&amp;quot;&amp;gt;4. Results in abstracts were by ulcer, final paper involved selection of 1 ulcer at random per patient. &amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 120%;&amp;quot;&amp;gt;'''Kill or Update By:''' July 2021&amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 120%;&amp;quot;&amp;gt;'''Citation/s:'''&amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 120%;&amp;quot;&amp;gt;1. Abidia A, Kuhan G, Laden G, Bahia H, Johnson B, Wilkinson A, Renwick P, Masson E, McCollum P. Role of hyperbaric oxygen therapy in ischaemic, diabetic, lower-extremity ulcers: a double-blind randomized controlled study. British Journal of Surgery [Surgical Research Society Abstracts] 2001; 88(5):744. &amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 120%;&amp;quot;&amp;gt;2. Abidia A, Kuhan G, Laden G, Bahia H, Johnson B, Wilkinson A, Renwick P, Masson E, McCollum P. Hyperbaric oxygen therapy for diabetic leg ulcers- a double-blind randomised-controlled trial. Undersea and Hyperbaric Medicine 2001; 28(Suppl):64. &amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 120%;&amp;quot;&amp;gt;3. Abidia A, Laden G, Kuhan G, Johnson BF, Wilkinson AR, Renwick PM, Masson EA, McCollum PT. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial. European Journal of Vascular Surgery 2003; 25:513-518. &amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-family: Arial,Helvetica,sans-serif; font-size: 120%;&amp;quot;&amp;gt;4.Abidia A, Kuhan G, Laden G, Bahia H, Johnson B, Wilkinson A, Renwick P, Masson E, McCollum P. Hyperbaric oxygen therapy for diabetic leg ulcers- a double-blind randomised-controlled trial. Undersea and Hyperbaric Medicine 2001; 28(1):48.&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:sumhorsa.gif|center]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&lt;br /&gt;
&amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;color: #7c00ff; display: block; font-family: arial,helvetica,sans-serif; font-size: 26px; text-align: center;&amp;quot;&amp;gt;'''[[Non-healing wounds  |  BACK]]'''&amp;lt;/span&amp;gt;&lt;/div&gt;</summary>
		<author><name>Gordoben</name></author>
		
	</entry>
</feed>